Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT00151242 · COMPLETED
Trial details
- NCT number
- NCT00151242
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2011-08-01
- Enrollment
- 920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.